225 related articles for article (PubMed ID: 19243386)
1. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
[TBL] [Abstract][Full Text] [Related]
2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Kandil DH; Cooper K
Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
[TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
7. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
8. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
9. A rare case of alpha-fetoprotein-producing early gastric cancer.
Shimoyama S; Nozaki K; Kaminishi M; Motoi N; Murakami T
Hepatogastroenterology; 2001; 48(39):687-91. PubMed ID: 11462904
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Pitman MB; Triratanachat S; Young RH; Oliva E
Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the AT motif binding factor-1 expression in alpha-fetoprotein producing gastric cancer: is it an event for differentiation and proliferation of the tumors?
Iida M; Imura J; Furuichi T; Sawada T; Nagawa H; Fujimori T
Oncol Rep; 2004 Jan; 11(1):3-7. PubMed ID: 14654895
[TBL] [Abstract][Full Text] [Related]
12. Two types of lymphatic invasion in lymph node metastasis with special references to the morphology of gastric carcinomas and immunohistology of e-cadherin and -catenin.
Obana S; Uda H; Kuwabara H; Sakamoto H
Kobe J Med Sci; 2002 Apr; 48(1-2):43-54. PubMed ID: 12151719
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
[TBL] [Abstract][Full Text] [Related]
14. Solitary AFP- and PIVKA-II-producing hepatoid gastric cancer with giant lymph node metastasis.
Iso Y; Sawada T; Shimoda M; Rokkaku K; Ohkura Y; Kubota K
Hepatogastroenterology; 2005; 52(66):1930-2. PubMed ID: 16334809
[TBL] [Abstract][Full Text] [Related]
15. [Immunocytohistochemical studies of AFP producing gastric cancer--cytomorphology and characteristics of AFP positive cells].
Kato T; Takahashi H; Ida Y; Watanabe Y; Sato Y; Takeda B
Rinsho Byori; 1993 Sep; 41(9):1024-30. PubMed ID: 7504755
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.
Wang XY; Degos F; Dubois S; Tessiore S; Allegretta M; Guttmann RD; Jothy S; Belghiti J; Bedossa P; Paradis V
Hum Pathol; 2006 Nov; 37(11):1435-41. PubMed ID: 16949914
[TBL] [Abstract][Full Text] [Related]
18. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
[TBL] [Abstract][Full Text] [Related]
19. Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.
Anatelli F; Chuang ST; Yang XJ; Wang HL
Am J Clin Pathol; 2008 Aug; 130(2):219-23. PubMed ID: 18628090
[TBL] [Abstract][Full Text] [Related]
20. Identification of glypican-3 as a novel tumor marker for melanoma.
Nakatsura T; Kageshita T; Ito S; Wakamatsu K; Monji M; Ikuta Y; Senju S; Ono T; Nishimura Y
Clin Cancer Res; 2004 Oct; 10(19):6612-21. PubMed ID: 15475451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
